The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. EFPIA believes that interactions between the pharmaceutical industry and healthcare professionals have a profound and positive influence on the quality of patient treatment and the value of future research and therefore, requires transparency to these interactions through the EFPIA Disclosure Code. Country specific Industry Associations transposed this Code into local Codes which went into effect on January 1, 2015.
Shire and Takeda support the principles of transparency put forth by EFPIA and is committed to ensuring we meet the highest degree of integrity expected by our patients, healthcare professionals, healthcare organizations and other stakeholders.
Below are all of Shire and Takeda’s Disclosure reports: